Demand for infant formula that mimics human milk

By Noli Dinkovski contact

- Last updated on GMT

SN-2 palmitate allows infant formula makers to offer benefits similar to mother’s milk
SN-2 palmitate allows infant formula makers to offer benefits similar to mother’s milk

Related tags: Infant formula, Nutrition

Demand for infant formula containing SN-2 palmitate – an ingredient that mimics the fatty acid profile in human milk – has soared over the past decade and will continue to grow, Advanced Lipids has claimed.

Advanced Lipids markets and sells InFat, a SN-2 palmitate fat ingredient that it said allowed infant formula manufacturers to offer many benefits similar to mother’s milk.

When it was set-up in 2007, five infant formula brands were using InFat. Today, that figure has risen to more than 150, Advanced Lipids said.

Clinically proven in several studies

InFat was clinically proven in several studies done in Israel and China to increase fat and calcium absorption, improve bone matrix quality, improve stool consistency, and have a positive effect on the development of the intestinal microbiome, said Ronald van der Knaap, chief executive of Advanced Lipids.

“It was also shown recently to improve baby’s wellbeing and the quality of life of their parents by reducing crying time and increasing sleep duration,”​ he adds.

Advanced Lipids is a joint venture between Israeli firm Enzymotec and AAK.

Please click here to sign-up for our free monthly Food Ingredients, Health & Nutrition (FIHN) newsletter.

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars